Envista Holdings Corporation 0HV.F Stock
Envista Holdings Corporation Price Chart
Envista Holdings Corporation 0HV.F Financial and Trading Overview
Envista Holdings Corporation stock price | 18.5 EUR |
Previous Close | 28.82 EUR |
Open | 29.48 EUR |
Bid | 29.26 EUR x N/A |
Ask | 30.41 EUR x N/A |
Day's Range | 29.48 - 29.48 EUR |
52 Week Range | 29.48 - 39.72 EUR |
Volume | 50 EUR |
Avg. Volume | 18 EUR |
Market Cap | 4.83B EUR |
Beta (5Y Monthly) | 1.430551 |
PE Ratio (TTM) | 26.321428 |
EPS (TTM) | -0.56 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 52.5 EUR |
0HV.F Valuation Measures
Enterprise Value | 5.79B EUR |
Trailing P/E | 26.321428 |
Forward P/E | 13.840375 |
PEG Ratio (5 yr expected) | -6.64 |
Price/Sales (ttm) | 1.8815293 |
Price/Book (mrq) | 1.1278167 |
Enterprise Value/Revenue | 2.258 |
Enterprise Value/EBITDA | 11.851 |
Trading Information
Envista Holdings Corporation Stock Price History
Beta (5Y Monthly) | 1.430551 |
52-Week Change | -9.80% |
S&P500 52-Week Change | 20.43% |
52 Week High | 39.72 EUR |
52 Week Low | 29.48 EUR |
50-Day Moving Average | 32.84 EUR |
200-Day Moving Average | 33.9 EUR |
0HV.F Share Statistics
Avg. Volume (3 month) | 18 EUR |
Avg. Daily Volume (10-Days) | 5 EUR |
Shares Outstanding | 163.7M |
Float | 163.16M |
Short Ratio | N/A |
% Held by Insiders | 0.33% |
% Held by Institutions | 115.61% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 8.26% |
Operating Margin (ttm) | 13.48% |
Gross Margin | 57.83% |
EBITDA Margin | 19.05% |
Management Effectiveness
Return on Assets (ttm) | 3.28% |
Return on Equity (ttm) | 5.08% |
Income Statement
Revenue (ttm) | 2.56B EUR |
Revenue Per Share (ttm) | 15.71 EUR |
Quarterly Revenue Growth (yoy) | -0.70% |
Gross Profit (ttm) | 1.49B EUR |
EBITDA | 488.7M EUR |
Net Income Avi to Common (ttm) | 211.4M EUR |
Diluted EPS (ttm) | 1.12 |
Quarterly Earnings Growth (yoy) | -41.50% |
Balance Sheet
Total Cash (mrq) | 585.2M EUR |
Total Cash Per Share (mrq) | 3.58 EUR |
Total Debt (mrq) | 1.53B EUR |
Total Debt/Equity (mrq) | 35.86 EUR |
Current Ratio (mrq) | 1.23 |
Book Value Per Share (mrq) | 26.139 |
Cash Flow Statement
Operating Cash Flow (ttm) | 182.3M EUR |
Levered Free Cash Flow (ttm) | 209.28M EUR |
Profile of Envista Holdings Corporation
Country | Germany |
State | CA |
City | Brea |
Address | Building E |
ZIP | 92821-6208 |
Phone | 714 817 7000 |
Website | https://envistaco.com |
Industry | Medical Instruments & Supplies |
Sector(s) | Healthcare |
Full Time Employees | 12700 |
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant for treatment planning of dental implants; DTX Studio Lab for prosthetics treatment planning; and DTX Studio Clinic, a software package offered with its imaging devices. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related consumables; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, Gendex, i-CAT, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
Q&A For Envista Holdings Corporation Stock
What is a current 0HV.F stock price?
Envista Holdings Corporation 0HV.F stock price today per share is 18.5 EUR.
How to purchase Envista Holdings Corporation stock?
You can buy 0HV.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Envista Holdings Corporation?
The stock symbol or ticker of Envista Holdings Corporation is 0HV.F.
Which industry does the Envista Holdings Corporation company belong to?
The Envista Holdings Corporation industry is Medical Instruments & Supplies.
How many shares does Envista Holdings Corporation have in circulation?
The max supply of Envista Holdings Corporation shares is 171.86M.
What is Envista Holdings Corporation Price to Earnings Ratio (PE Ratio)?
Envista Holdings Corporation PE Ratio is now.
What was Envista Holdings Corporation earnings per share over the trailing 12 months (TTM)?
Envista Holdings Corporation EPS is -0.56 EUR over the trailing 12 months.
Which sector does the Envista Holdings Corporation company belong to?
The Envista Holdings Corporation sector is Healthcare.